New Key Statistics Module, Z-Score and F-Score
NAS:TCRT Key Ratios
Market Cap $ M | 22.26 |
Enterprise Value $ M | 14.59 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.56 |
Price/Sales | 278.00 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -2.29 |
Beneish M-Score | 36.31 |
10-y EBITDA Growth Rate % | -5.90 |
5-y EBITDA Growth Rate % | -48.20 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.44 |
EV-to-EBITDA | -0.47 |
PEG | -- |
Shares Outstanding M | 16.01 |
Net Margin (%) | -702,800.00 |
Operating Margin % | -569,860.00 |
Pre-tax Margin (%) | -702,800.00 |
Quick Ratio | 4.22 |
Current Ratio | 4.22 |
ROA % (ttm) | -103.84 |
ROE % (ttm) | -159.84 |
ROIC % (ttm) | -208.61 |
Dividend Yield % | -- |
Altman Z-Score | -161.17 |
Piotroski F-Score | 4.00 |
Positive ROA | N |
Positive CFROA | N |
Higher ROA y-y | N |
Cash flow > Earnings | Y |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | Y |
Less Shares Outstanding y-y | Y |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | N |
TCRT Number of Guru Trades
TCRT Volume of Guru Trades
Gurus Latest Trades with NAS:TCRT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TCRT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Alaunos Therapeutics Inc Insider Transactions
No Available Data
News about NAS:TCRT
Total 0- 1